In addition, the fact that VEGF-TKIs are associated with a high risk of thrombocytopenia and bleeding represents a challenge for the medical and interventional treatment of myocardial ischemia [4,31,32,33]. The gene discussed is VEGFA; the disease is myocardial ischemia.